Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Capstone Therapeutics Corp. (CAPS)
|
Add to portfolio |
|
|
|
| Price: |
$17.25
| | Metrics |
| OS: |
54.4
|
M
| |
|
|
| Market cap: |
$938
|
M
| |
|
|
|
Net debt:
|
$2.34
|
M
| |
|
|
|
EV:
|
$940
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($2.3)
|
M
| |
|
|
|
EBIT
|
($2.4)
|
M
| |
|
|
| EPS |
($6.99)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | | | | | | | |
| Selling, general and administrative | | | | | | | | |
| Research and development | 1.4 | 1.0 | 1.0 | 1.2 | 3.1 | 3.1 | 2.4 | 6.4 |
| General and administrative | 0.6 | 0.6 | 0.5 | 1.8 | 1.5 | 1.2 | 1.8 | 3.5 |
| EBITA | 0.0 | -1.5 | 1.9 | 3.0 | 4.6 | 4.3 | 4.1 | 9.9 |
| EBITA margin | -1.2% | | | | | | | |
| Amortization of intangibles | 0.2 | 0.2 | 0.2 | | | | | |
| EBIT | -0.2 | -1.7 | 1.7 | 3.0 | 4.6 | 4.3 | 4.1 | 9.9 |
| EBIT margin | -9.1% | | | | | | | |
| Pre-tax income | -0.4 | -1.8 | 1.7 | 3.0 | 4.6 | 4.1 | 4.1 | 9.9 |
| Income taxes | -0.1 | 0.0 | 0.1 | 0.2 | 0.4 | 0.0 | 0.0 | 0.2 |
| Tax rate | 12.0% | 2.0% | 3.4% | 6.5% | 8.8% | 0.5% | 0.0% | 1.6% |
| Net income | -0.4 | -1.8 | 0.7 | 2.8 | 4.2 | 3.9 | 3.6 | 9.7 |
| Net margin | -19.0% | | | | | | | |
| |
| Diluted EPS | ($6.99) | ($37.20) | $0.02 | $0.07 | $0.10 | $0.10 | $0.09 | $0.24 |
| Shares outstanding (diluted) | 0.1 | 0.0 | 40.9 | 40.9 | 40.9 | 40.9 | 40.9 | 40.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|